A client who is being treated for cancer has expressed interest in exploring complementary and alternative therapies. What is the nurse's best action?

A client who is being treated for cancer has expressed interest in exploring complementary and alternative therapies. What is the nurse's best action?

• A. All treatments should be encouraged unless there are known and significant contraindications.
• B. CAM therapies should be discouraged entirely.
• C. Only conventional therapies should be discussed.
• D. The nurse should avoid CAM topics.

Answer: (A)

Open, nonjudgmental discussion of complementary and alternative therapies is essential in cancer care because patients may pursue CAM options alongside conventional treatments, and safety hinges on understanding how these therapies interact with chemotherapy, radiation, and supportive care. The best action is to encourage all treatments the patient is considering, as long as there are known and significant contraindications, while carefully assessing each modality for safety and evidence. This approach respects the patient’s autonomy and helps keep care coordinated, enabling the nurse to monitor for potential drug–herb interactions, side effects, or interference with treatment goals, and to guide the patient toward safe, evidence-based information or reputable CAM resources. It also fosters trust and open communication so concerns can be addressed and integrated into the overall treatment plan rather than avoided or dismissed. Limiting discussion to conventional therapies or discouraging CAM entirely would miss opportunities to ensure safety, while avoiding CAM topics altogether would neglect the patient’s values and preferences.

Open, nonjudgmental discussion of complementary and alternative therapies is essential in cancer care because patients may pursue CAM options alongside conventional treatments, and safety hinges on understanding how these therapies interact with chemotherapy, radiation, and supportive care. The best action is to encourage all treatments the patient is considering, as long as there are known and significant contraindications, while carefully assessing each modality for safety and evidence. This approach respects the patient’s autonomy and helps keep care coordinated, enabling the nurse to monitor for potential drug–herb interactions, side effects, or interference with treatment goals, and to guide the patient toward safe, evidence-based information or reputable CAM resources. It also fosters trust and open communication so concerns can be addressed and integrated into the overall treatment plan rather than avoided or dismissed. Limiting discussion to conventional therapies or discouraging CAM entirely would miss opportunities to ensure safety, while avoiding CAM topics altogether would neglect the patient’s values and preferences.